Zentek Ltd. (ZTEK)

1.4500 -0.0200 (-1.36%) At close: 03:58PM EST

Zentek Ltd.

1205 Amber Drive
Suite 210
Thunder Bay, ON P7B 6M4
Canada

https://www.zentek.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Francis Dube B.Sc.	Exec. Chairman	137.8k	N/A	N/A
Mr. Gregory Fenton C.F.A.	CEO & Director	150.33k	N/A	N/A
Mr. Brian Bosse B.A., C.F.A.	COO & Director	80.17k	N/A	1973
Ms. Wendy Ford CA, CPA	Chief Financial Officer	N/A	N/A	N/A
Mr. Ryan Shacklock	VP of Strategy, Bus. Devel. & Investor Relations	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.

Corporate Governance

Zentek Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.